B-Cell Phenotyping Profile for Immunodeficiency and Immune Competence Assessment, Blood
- As an aid in diagnosis of common variable immunodeficiency
- As an aid in diagnosis of hyper-IgM syndromes
- Therapy monitoring for B-cell directed therapies
- Therapy monitoring in immunetransplant and HIV infected patients
- Interpretive report and quantitative information is provided on the various B cell subsets. Table 1 shows B cell panels and subsets.
- All specimens are evaluated for the total number of CD19+ B cells present in the peripheral blood mononuclear cell population and their results are compared to reference range.
- B cell phenotyping results should be always correlated with clinical findings.
Table 1. The B cell panels for evaluation of B cell subgroups. Report will represent percentage and absolute counts in cells/microliter.
B cell panel B cell subgroup
CD19+ CD19 expressing B cells (percentage of whole lymphocytes)
CD19+ CD27+ Memory B cells
CD19+ CD27+ IgD+ IgM+ nonswitched or marginal zone memory B cells
CD19+ CD27+ IgD- IgM+ IgM-only expressing memory B cells
CD19+ CD27+ IgD- IgM- class-switched memory B cells
CD19+ IgM+ IgM expressing B cells
CD19+ CD38+ IgM+ transitional B cells
CD19+ CD38+ IgM- plasmablasts
CD19+ CD21- immature B cells
CD19+ CD21+ mature b cells
CD19+ CD20+ Coexpression of CD19 and CD20
B cell numbers may be normal, moderately decreased or in 10% of cases significantly decreased (less than one percent of whole peripheral leukocytes)
Whole Blood EDTA (lavender top).
Stability
Refrigerated: 48 hours
- Blood 2002 Mar 1;99(5):1544-51; [PMID: 11861266].
- Autoimmun Rev. 2008 Feb;7(4):309-12. [PMID: 18295735]
- Pathology. 2008 Apr;40(3):288-94. [PMID: 18428049]
- Blood 2005 Mar 1;105(5):1881-90; [PMID: 15358621]
- Pediatr Res. 2004 Oct;56(4):519-25. [PMID: 15319456]
- Eur J Immunol 2000 Sep;30(9):2516-20; [PMID: 11009084]